CCENDU Bulletin: An Update on Stimulant Use and Related Harms in Canada and the United States
This bulletin summarizes the most recent updates on stimulant use and related harms in Canada and the United States.
Evaluation of Psychoactive Substances that Bring Youth to the Emergency Department
Examines the trends in substance-related visits to the emergency department (ED) among youth and young adults (12 to 24 years old) and the context of their visits.
Clearing the Smoke on Cannabis: Cannabis Use and Driving – An Update
Presents the latest clinical evidence on cannabis use and impaired driving among Canadians.
Opioids (Canadian Drug Summary)
Summarizes data on the use of opioids, including the medical and nonmedical use, effects and legal status.
Standing Committee on Health: Canada’s Health Workforce Brief (Policy Brief)
A version of this document was submitted to the Standing Committee on Canada’s Health Workforce in May 2022.
Standing Committee on Health: Women’s Health Brief
Submitted to the Standing Committee on Health on Women’s Health in October 2022.
Submission for the Pre-Budget Consultations in Advance of the 2022–2023 Federal Budget
Submitted to the Standing Committee on Finance October 2022.
3-4 Methylenedioxy-methamphetamine (MDMA, Ecstasy or Molly) (Canadian Drug Summary)
Summarizes data on the use of 3-4 methylenedioxy-methamphetamine (MDMA, ecstasy or Molly), including the harms, effects and legal status.
